Financial Wire

Intertek Group Soars After Strong First-Quarter Results, Launches Review of Potential Business Split

-- Intertek Group (ITRK.L) shares climbed over 12% higher on Tuesday, buoyed by robust first-quarter trading results and the announcement of a strategic review aimed at potentially separating its energy infrastructure and testing divisions.

The British assurance, testing, and certification company is evaluating the potential separation of its Intertek Energy & Infrastructure and Intertek Testing & Assurance. The review aims to determine if separate, specialist entities would drive faster market execution and better long-term shareholder returns.

The move, which will be implemented by mid-2027 through either a sale or demerger, is intended to help accelerate the businesses' growth in a "highly attractive and growing" quality assurance sector.

RBC Capital Markets held a positive sentiment over the "leftfield" strategic review, as it noted that buyers are "likely to tread carefully" amid a challenging geopolitical landscape.

"A demerger runs the risk of cost duplications and less liquid entities with a smaller investor audience, but we think many investors will view the prospects for sustained independence as limited given the appetite for consolidation by the biggest global players," RBC said in a quick-take report, adding that investor focus is likely to shift quickly to potential acquirers and whether standalone units could command higher valuation multiples.

Intertek also reported an increase in group revenue for the three months ended March 31 at 838.5 million pounds sterling, up 3.7% at actual rates and 6.7% at constant currency. The company's like-for-like revenue came in at 828.3 million pounds, 2.4% higher year-on-year at actual rates and 5.4% at constant exchange rates.

Chief Executive Officer André Lacroix said the group made a "strong start" to 2026, driven by Consumer Products, double-digit growth in risk-based assurance within Corporate Assurance, and solid demand across Health and Safety and Industry and Infrastructure. "Operating cash flow and free cash flow were strong which, combined with our strong balance sheet, enables us to continue to invest to seize the exciting growth opportunities ahead," he added.

Within this context, Intertek affirmed its full-year 2026 outlook, saying it is "on track" to deliver mid-single digit like-for-like revenue growth on a constant currency basis, sustained margin expansion, and "strong" earnings growth and free cash flow.

Related Articles

Australia

Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility

Arcus Biosciences (RCUS) said Monday it discontinued its phase 3 STAR-121 study in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee recommended stopping the trial for futility.The study, conducted in collaboration with Gilead Sciences (GILD), evaluated domvanalimab plus zimberelimab and chemotherapy versus pembrolizumab plus chemotherapy as a first-line treatment, the company said.The decision followed a pre-planned futility analysis indicating the treatment was unlikely to meet its primary endpoint.Shares of Arcus Biosciences were down 5% in Monday trading.Price: $23.05, Change: $-1.20, Percent Change: -4.95%

$GILD$RCUS
Australia

Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal

Sila Realty Trust (SILA) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion.Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's closing price on Friday, the companies said Monday.The transaction, which requires approval from Sila's shareholders, is anticipated to complete in the second or third quarter of this year. Upon completion, the company will be delisted from the New York Stock Exchange."The consummation of this transaction will provide significant and immediate realized benefit to our shareholders," Sila Chief Executive Michael Seton said in a statement.Shares of Sila were up 19% in Monday trade. Asset manager Blue Owl rose 1%.Sila, which is focused on investing in healthcare facilities, said its portfolio comprised 137 real estate properties and three undeveloped land parcels in the US as of end-March. Data on its website showed its portfolio includes 86 medical outpatient buildings, 25 inpatient rehabilitation facilities, and 26 surgical and specialty facilities."This transaction provides us with a compelling opportunity to acquire a scaled portfolio with durable cash flows and attractive long-term growth characteristics, while further expanding Blue Owl managed funds' exposure to an asset class and sector we view as both resilient and essential given its critical role in both society and the economy," Marc Zahr, co-president and global head of real assets at Blue Owl, said.In February, Sila reported fourth-quarter adjusted funds from operations of $0.55 per share, up from $0.54 a year ago. Revenue rose to $50.7 million from $46.5 million.Sila plans to pay up to two regular quarterly dividends ahead of deal completion.Price: $30.44, Change: $+4.90, Percent Change: +19.19%

$OWL$SILA
Australia

Carnival Shareholders Approve Single Company Structure, Redomiciliation

Carnival (CCL, CUK) said Monday that majority of its shareholders approved the proposal to simplify its dual-listed structure into a single company and the redomiciliation of Carnival Corporation to Bermuda from Panama.The company said it expects the proposed changes to become effective on May 7.Price: $28.69, Change: $-0.53, Percent Change: -1.81%

$CCL$CUK